Natus Medical raises FY and Q2 revenue guidance
Neuron diagnostic and newborn care products manufacturer Natus Medical Inc. (Nasdaq:BABY) this morning raised its full year and second quarter 2008 revenue guidance to reflect its recent acquisition of Sonamed and the recent completion of two underwritten stock offerings.
Shares were halted in pre-market trading. For detailed price information and recent news stories about Natus Medical, click BABY.
For access to the full article, you must be a registered member - it's FREE.
Already a member? Please log in below
Not Registered?
Register today and enjoy all that SmallCapInvestor.com has to offer, including:
- Daily small cap stock profiles.
- Intra-day coverage of Russell 2000 companies.
- Research and insights from our analysts.
- Special reports.
